Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population

Abstract

French

Background:

Limited data are available on the epidemiologic features of psoriasis in Canada.

Objective:

To investigate the epidemiologic features and burden of moderate-to-severe psoriasis in a Canadian population.

Methods:

An online survey was conducted using a consumer panel. Eligible respondents indicated a diagnosis of psoriasis and plaque-type psoriasis of at least moderate severity. Eligibility was validated according to self-reported body surface area (BSA) involvement, sensitive areas affected, and/or current treatment.

Results:

Of the 514 respondents who completed the survey, 62% estimated a BSA involvement of ≥ 3% within the past 5 years. Onset of psoriasis occurred earlier in females than in males. Nail involvement was more commonly reported in individuals with psoriatic arthritis compared to those without. Several symptoms were more likely described as “constantly” or “near constantly” experienced by females than by males. Comorbidities commonly reported were hypertension, dyslipidemia, and overweight or obesity.

Conclusions:

The findings are consistent with a substantial burden attributed to moderate-to-severe plaque psoriasis in a Canadian population.

Get full access to this article

View all access options for this article.

References

Langley

Krueger

Griffiths

. Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005;64 Suppl 2:ii18–23; discussion ii4–5.

Gottlieb

Chao

Dann

. Psoriasis comorbidities. J Dermatolog Treat 2008;19:5–21.

Choi

Koo

. Quality of life issues in psoriasis. J Am Acad Dermatol 2003;49 (2 Suppl):S57–61.

Canadian Psoriasis Guidelines Committee. Canadian guidelines for the management of plaque psoriasis, June 2009. Available at: http://www.dermatology.ca/psoriasisguidelines (accessed September 28, 2009).

Boudreau

Blackhouse

Goeree

Mierzwinski-Urban

. Adalimumab, alefacept, efalizumab, etanercept, and infliximab for severe psoriasis vulgaris in adults: budget impact analysis and review of comparative clinical- and cost-effectiveness Ottawa: Canadian Agency for Drugs and Technologies in Health; 2007. Technology report number 97.

Nall

Gulliver

Charmley

Farber

. Search for the psoriasis susceptibility gene: The Newfoundland Study. Cutis 1999;64:323–9.

Gelfand

Stern

Nijsten

. The prevalence of psoriasis in African Americans: Results from a population-based study. J Am Acad Dermatol 2005;52:23–6.

Koo

. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996;14:485–96.

Stern

Nijsten

Feldman

. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004;9:136–9.

10.

Barisic-Drusko

Paljan

Kansky

Vujasinovic

. Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl (Stockh) 1989;146:178–9.

11.

Farber

Nall

. Epidemiology: Natural history and genetics. In: Roenigk

Jr Maibach

, editors. Psoriasis. New York: Marcel Dekker; 1998. p. 107–57.

12.

Naldi

. Inflammatory skin diseases IV: Psoriasis. In: Strachan

, editor. The challenge of dermato-epidemiology. Boca Raton (FL): CRC Press; 1997. p. 175–87.

13.

Yip

. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 1984;10:965–8.

14.

Lin

. Psoriasis in China. J Dermatol 1993;20:746–55.

15.

Shao

Zhang

Wang

. Distribution of psoriasis in China: A nationwide screening. Proc Chin Acad Med Sci Peking Union Med Coll 1987;2:59–65.

16.

Brandrup

Green

. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981;61:344–6.

17.

Lomholt

. Psoriasis: prevalence, spontaneous course, and genetics [PhD thesis]. Copenhagen: G.E.C. GAD; 1963.

18.

Braathen

Botten

Bjerkedal

. Prevalence of psoriasis in Norway. Acta Derm Venereol Suppl (Stockh) 1989;142:5–8.

19.

Kavli

Forde

Arnesen

Stenvold

. Psoriasis: Familial predisposition and environmental factors. Br Med J (Clin Res Ed) 1985;291:999–1000.

20.

Kavli

Stenvold

Vandbakk

. Low prevalence of psoriasis in Norwegian Lapps. Acta Derm Venereol 1985;65:262–3.

21.

Falk

Vandbakk

. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh) 1993;182:6–9.

22.

Convit

. Investigation of the incidence of psoriasis among Latin American Indians. In: Proceedings of the 13th Congress on Dermatology, Amsterdam; 1962. p. 196.

23.

Hellgren

. Psoriasis: the prevalence in sex, age and occupational groups in total populations in Sweden; morphology, inheritance and association with other skin and rheumatic diseases. Stockholm: Almqvist & Wiksell; 1967.

24.

Rea

Newhouse

Halil

. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976;30:107–14.

25.

Nevitt

Hutchinson

. Psoriasis in the community: Prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996;135:533–7.

26.

Johnson

Roberts

. Skin conditions and related need for medical care among persons 1–74 years: United States, 1971–1974. In: U. S. Department of Health, editor. Data from the National Health Survey, no. 212, DHEW Publication No. (PHS) 79- 1660. Hyattsville (MD): Government Printing Office; 1978. p. 1–72.

27.

Christophers

. Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol 2001;26:314–20.

28.

Gudjonsson

Elder

. Psoriasis: Epidemiology. Clin Dermatol 2007;25:535–46.

29.

Ferrandiz

Bordas

Garcia-Patos

. Prevalence of psoriasis in Spain (Epiderma Project: Phase I). J Eur Acad Dermatol Venereol 2001;15:20–3.

30.

Raychaudhuri

Farber

. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001;15:16–7.

31.

Wasel

Poulin

Andrew

. A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patients. J Cutan Med Surg 2009;13:294–302.

32.

Wozel

. Psoriasis treatment in difficult locations: Scalp, nails, and intertriginous areas. Clin Dermatol 2008;26:448–59.

33.

Menter

Gottlieb

Feldman

. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008;58:826–50.

34.

Ware

Kosinski

Dewey

Gandek

. How to score and interpret single-item health status measures: a manual for users of the SF-8™ Health Survey. Lincoln (RI): QualityMetric; 2001.

35.

Finlay

Khan

. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–6.

36.

Ware

Kosinski

Dewey

Gandek

. A manual for users of the SF-8 Health Survey. Lincoln (RI): QualityMetric; 2001.

37.

Yang

Wallenstein

Hagan

. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008;17:113–21.

38.

Ware

Kosinski

Bjorner

. User's manual for the SF-36® Health Survey (version 2). 2nd ed. Lincoln (RI): QualityMetric; 2007.

39.

Krueger

Koo

Lebwohl

. The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280–4.

40.

Fry

. Psoriasis. Br J Dermatol 1988;119:445–61.

41.

Ferrandiz

Pujol

Garcia-Patos

. Psoriasis of early and late onset: A clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002;46:867–73.

42.

Duffin

Chandran

Gladman

. Genetics of psoriasis and psoriatic arthritis: Update and future direction. J Rheumatol 2008;35:1449–53.

43.

Christensen

Callis

Papenfuss

. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J Invest Dermatol 2006;126:2397–403.

44.

Gupta

. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995;34:700–3.

45.

Kononen

Torppa

Lassus

. An epidemiological survey of psoriasis in the greater Helsinki area. Acta Derm Venereol Suppl (Stockh) 1986;124:1–10.

46.

Inerot

Enerback

Enlund

. Collecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders. BMC Dermatol 2005;5:10.

47.

Krueger

Feldman

Camisa

. Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000;43:281–5.

48.

Warren

Brown

Griffiths

. Topical treatments for scalp psoriasis. Drugs 2008;68:2293–302.

49.

Gupta

. Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:241–2.

50.

Kimball

Jacobson

Weiss

. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005;6:383–92.

51.

Ramsay

O'Reagan

. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988;118:195–201.

52.

Fried

Friedman

Paradis

. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101–5.

53.

Weiss

Kimball

Liewehr

. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002;47:512–8.

54.

Rapp

Feldman

Exum

. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401–7.

55.

Gottlieb

Dann

Menter

. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008;7:563–72.

56.

Kimball

Robinson

. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology 2008;217:27–37.

57.

Kaye

Jick

. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008;159:895–902.

58.

Cohen

Sherf

Vidavsky

. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008;216:152–5.

59.

World Health Organization Global InfoBase: data for saving lives (Canadian data). Available at: http://www.who.int/infobase/report.aspx?rid=111&iso=CAN (accessed February 10 2009).

60.

Martin

Leff

Calonge

. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000;18:215–8.

61.

Novak

Kroutil

Williams

Van Brunt

. The nonmedical use of prescription ADHD medications: Results from a national Internet panel. Subst Abuse Treat Prev Policy 2007;2:32.

62.

Schmitt

Ford

. Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis—a structural equations modeling approach. Gen Hosp Psychiatry 2007;29:134–40.

63.

De Korte

Mombers

Sprangers

Bos

. The suitability of quality-of-life questionnaires for psoriasis research: A systematic literature review. Arch Dermatol 2002;138:1221–7; discussion 7.